Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by cryptopheron Aug 21, 2022 1:34pm
209 Views
Post# 34910078

RE:Datametrex needs Analyst Coverage

RE:Datametrex needs Analyst CoverageAiking I completely agree
Knowing MG has a marketing plan to coincide with uplist as communicated by the recent outgoing IR lady Kristina Colpitts along with MG's stated claim that roadshows for investor/client/industry conferences is to be part of the strategy and something that investors can look forward to see, one can only assume that his key focus of his engagement efforts with institutions that he said he began in the spring has the design to obtain a institution or multiple institutions initiating coverage of DM.

There's a lot of potential developments that are coming down the pipe for this fall just as analyst's & fund managers are getting back to their desks from summer vacation.

I think we could be in store for a lot of eye balls returning to DM come September-October and the return of those good old 10-20-30 million volume days that we saw in the past

Although I'm disappointed like many here that new investors buying into DM right now are seizing the (unbelievable to me) opportunity to buy DM for the same price right now as two years ago or $60 Million in Revenue / $40 Million Federal Government Contract Award + two brand new revenue earning verticals ago.
What a Deal for them eh!

Will buying DM early and adding through the dips turn out to be the best mistake I ever made , history will be my judge , but if the large buy I did when it hit 1.5 cents is any indication then maybe there's a delightful ending to this story.

Plus I take great solitude when looking at the 5 year chart in seeing the super strong base all across the 10 cent line as compared to the 1.5 falling knife scenario and knowing how pristine the balance sheet is.

I don't think it's a stretch for DM to sign on a lot of their Hollywood North film and streaming clients to MediCall now with the mental health oversight segment for improving employee health outcomes.
Just a hunch I have based on stuff I've been reading lately
jmho
https://www.dialogue.co/en/ultimateguide-telemedicine

Some more low hanging fruit that MediCall could go after is to offer online assessment and treatment for ADHD
https://www.forbes.com/sites/forbesbusinesscouncil/2022/08/18/online-treatment-for-adhd-what-telehealth-companies-should-know/?sh=7ba36e799ba1

I still haven't given up on this guy hitting it out of the ballpark either 
https://finance.yahoo.com/news/datametrex-hires-former-lotte-executive-130010447.html
<< Previous
Bullboard Posts
Next >>